Evidence map›Paper›PMID 15028766›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

An arginine involved in GABA binding and unbinding but not gating of the GABA(A) receptor.

David A Wagner, Cynthia Czajkowski, Mathew V Jones

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. GABAFrontiers in cellular neuroscience · 2020
    Article
  3. Loop G in the GABAThe Journal of physiology · 2017
    Article
  4. Article
  5. Article
  6. Role ofBiochemistry and biophysics reports · 2015
    Article
  7. Article
  8. Article
  9. Article
  10. Photo-antagonism of the GABAA receptor.Nature communications · 2014
    Article
  11. Article
  12. α1F64 Residue at GABA(A) receptor binding site is involved in gating by influencing the receptor flipping transitions.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David A WagnerDepartment of Physiology, University of Wisconsin, Madison, Wisconsin 53706, USA. david.wagner@marquette.edu
Cynthia Czajkowski
Mathew V Jones
University of Wisconsin–Madison · USMarquette University · US

Funding

STRUCTURE OF THE GABA A RECEPTOR BINDING SITESR01NS034727 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI CZAJKOWSKI, CYNTHIA M · 1997 to 2016
$6.1M
Structure of the GABA-A Receptor Binding SitesR56NS034727 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI CZAJKOWSKI, CYNTHIA M · 2012 to 2012
$513k
NINDS NIH HHS NS34727NINDS NIH HHS R01 NS034727NINDS NIH HHS R56 NS034727
6 · The paper itself

Abstract

GABA(A) receptor function can be conceptually divided into interactions between ligand and receptor (binding) and the opening and closing of the ligand-bound channel (gating). The relationship between binding, gating, and receptor structure remains unclear. Studies of mutations have identified many amino acid residues that contribute to the GABAbinding site. Most of these studies assayed changes in GABA dose-response curves, which are macroscopic measures that depend on the interplay of many processes and cannot resolve individual microscopic transitions. Understanding the microscopic basis of binding and gating is critical, because kinetic transition rates predict how receptors will behave at synapses. Furthermore, microscopic rates are directly related to the molecular interactions underlying receptor function. Here, we focused on a residue (beta2-R207) previously identified as lining the GABA-binding site that, when mutated to cysteine, greatly reduces apparent GABA affinity and was predicted to affect both binding and gating. To better understand the role of beta2-R207, we expressed alpha1beta2 and alpha1beta2-R207C receptors in human embryonic kidney 293 cells and studied receptor kinetics using fast solution applications. The mutation accelerated deactivation by 10-fold, without altering desensitization in the presence of saturating GABA. Maximum open probability and single-channel open times were also unaltered by the mutation, but the GABA-binding rate was reduced eightfold. Therefore, the effects of this mutation in a predicted binding site residue are solely attributable to changes in GABA-binding and unbinding kinetics, with no changes in channel gating. Because beta2-R207 stabilizes GABA in the binding pocket, it may directly contact the GABA molecule.

Indexed as

Amino Acid SubstitutionAnimalsArginineBinding, CompetitiveCell Linegamma-Aminobutyric AcidHumansIon Channel GatingKidneyLigandsMutagenesis, Site-DirectedPatch-Clamp TechniquesProtein BindingRatsReceptors, GABA-AStructure-Activity RelationshipArgininegamma-Aminobutyric AcidLigandsReceptors, GABA-A

Identifiers

PMID15028766
PMCPMC6729509
OpenAlexW2131561307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.